Tried and tested
With over 28 years of research & development and clinical studies, Nourkrin® is recognised by scientists, doctors, dermatologists and trichologists worldwide - making Nourkrin® the uncontested market leader in its category.
As the market leader within the field of hair growth disorders and hair loss:
Nourkrin® is committed to ensuring its recognition as a benchmark for excellence – not only by consumers, but also by scientists, dermatologists, cosmetologists and aestheticians worldwide.
Nourkrin® is based on more than 56 scientific studies and clinical papers, as well as several consumer studies published in leading peer-review journals.
Nourkrin® has been tested in placebo, double-blind studies and shown to be side effect free*. This is in contrast to other pharmaceuticals which may cause: scalp itching, dryness, scaling, flaking, irritation, burning and in extreme instances weight gain, and swelling of the face, ankles, hands, or stomach, as well as difficulty breathing (especially when lying down), rapid heartbeat, chest pain and light headedness**.
Nourkrin® continues to partner with the world’s leading authorities on hair loss and hair thinning based on its clinically documented efficacy and safety standards.
Nourkrin® contains naturally based ingredients that have been scientifically documented to be safe and effective.
*2006 and 2012 Study published in leading international clinical Journals
** Studies: Finastride: “Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W et al: Finastride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-589. and Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al: Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999; 40;930-937